244 related articles for article (PubMed ID: 19404392)
1. Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study.
Lingappa JR; Kahle E; Mugo N; Mujugira A; Magaret A; Baeten J; Bukusi EA; Cohen CR; Katabira E; Ronald A; Kiarie J; Farquhar C; Stewart GJ; Makhema J; Essex M; Were E; Fife K; Debruyn G; Gray G; McIntyre J; Manongi R; Kapiga S; Coetzee D; Allen S; Inambao M; Kayitenkore K; Karita E; Kanweka W; Delany S; Rees H; Vwalika B; Coombs RW; Morrow R; Whittington W; Corey L; Wald A; Celum C;
PLoS One; 2009; 4(4):e5272. PubMed ID: 19404392
[TBL] [Abstract][Full Text] [Related]
2. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
Celum C; Wald A; Lingappa JR; Magaret AS; Wang RS; Mugo N; Mujugira A; Baeten JM; Mullins JI; Hughes JP; Bukusi EA; Cohen CR; Katabira E; Ronald A; Kiarie J; Farquhar C; Stewart GJ; Makhema J; Essex M; Were E; Fife KH; de Bruyn G; Gray GE; McIntyre JA; Manongi R; Kapiga S; Coetzee D; Allen S; Inambao M; Kayitenkore K; Karita E; Kanweka W; Delany S; Rees H; Vwalika B; Stevens W; Campbell MS; Thomas KK; Coombs RW; Morrow R; Whittington WL; McElrath MJ; Barnes L; Ridzon R; Corey L;
N Engl J Med; 2010 Feb; 362(5):427-39. PubMed ID: 20089951
[TBL] [Abstract][Full Text] [Related]
3. Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2/HIV-1 coinfected persons: a randomized controlled trial.
Mujugira A; Magaret AS; Celum C; Baeten JM; Lingappa JR; Morrow RA; Fife KH; Delany-Moretlwe S; de Bruyn G; Bukusi EA; Karita E; Kapiga S; Corey L; Wald A;
J Infect Dis; 2013 Nov; 208(9):1366-74. PubMed ID: 23901094
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention.
Mujugira A; Baeten JM; Donnell D; Ndase P; Mugo NR; Barnes L; Campbell JD; Wangisi J; Tappero JW; Bukusi E; Cohen CR; Katabira E; Ronald A; Tumwesigye E; Were E; Fife KH; Kiarie J; Farquhar C; John-Stewart G; Kidoguchi L; Panteleeff D; Krows M; Shah H; Revall J; Morrison S; Ondrejcek L; Ingram C; Coombs RW; Lingappa JR; Celum C;
PLoS One; 2011; 6(10):e25828. PubMed ID: 21998703
[TBL] [Abstract][Full Text] [Related]
5. Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples.
Cohen CR; Lingappa JR; Baeten JM; Ngayo MO; Spiegel CA; Hong T; Donnell D; Celum C; Kapiga S; Delany S; Bukusi EA
PLoS Med; 2012; 9(6):e1001251. PubMed ID: 22745608
[TBL] [Abstract][Full Text] [Related]
6. Partner characteristics predicting HIV-1 set point in sexually acquired HIV-1 among African seroconverters.
Lingappa JR; Thomas KK; Hughes JP; Baeten JM; Wald A; Farquhar C; de Bruyn G; Fife KH; Campbell MS; Kapiga S; Mullins JI; Celum C;
AIDS Res Hum Retroviruses; 2013 Jan; 29(1):164-71. PubMed ID: 23061422
[TBL] [Abstract][Full Text] [Related]
7. Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes.
LeGoff J; Weiss HA; Gresenguet G; Nzambi K; Frost E; Hayes RJ; Mabey DC; Malkin JE; Mayaud P; Belec L
AIDS; 2007 Jul; 21(12):1569-78. PubMed ID: 17630552
[TBL] [Abstract][Full Text] [Related]
8. Sexually transmitted infections among HIV-1-discordant couples.
Guthrie BL; Kiarie JN; Morrison S; John-Stewart GC; Kinuthia J; Whittington WL; Farquhar C
PLoS One; 2009 Dec; 4(12):e8276. PubMed ID: 20011596
[TBL] [Abstract][Full Text] [Related]
9. Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.
Lingappa JR; Baeten JM; Wald A; Hughes JP; Thomas KK; Mujugira A; Mugo N; Bukusi EA; Cohen CR; Katabira E; Ronald A; Kiarie J; Farquhar C; Stewart GJ; Makhema J; Essex M; Were E; Fife KH; de Bruyn G; Gray GE; McIntyre JA; Manongi R; Kapiga S; Coetzee D; Allen S; Inambao M; Kayitenkore K; Karita E; Kanweka W; Delany S; Rees H; Vwalika B; Magaret AS; Wang RS; Kidoguchi L; Barnes L; Ridzon R; Corey L; Celum C;
Lancet; 2010 Mar; 375(9717):824-33. PubMed ID: 20153888
[TBL] [Abstract][Full Text] [Related]
10. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.
Donnell D; Baeten JM; Kiarie J; Thomas KK; Stevens W; Cohen CR; McIntyre J; Lingappa JR; Celum C;
Lancet; 2010 Jun; 375(9731):2092-8. PubMed ID: 20537376
[TBL] [Abstract][Full Text] [Related]
11. Impact of acyclovir on genital and plasma HIV-1 RNA, genital herpes simplex virus type 2 DNA, and ulcer healing among HIV-1-infected African women with herpes ulcers: a randomized placebo-controlled trial.
Mayaud P; Legoff J; Weiss HA; Grésenguet G; Nzambi K; Bouhlal H; Frost E; Pépin J; Malkin JE; Hayes RJ; Mabey DC; Bélec L;
J Infect Dis; 2009 Jul; 200(2):216-26. PubMed ID: 19530940
[TBL] [Abstract][Full Text] [Related]
12. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa.
Delany S; Mlaba N; Clayton T; Akpomiemie G; Capovilla A; Legoff J; Belec L; Stevens W; Rees H; Mayaud P
AIDS; 2009 Feb; 23(4):461-9. PubMed ID: 19155993
[TBL] [Abstract][Full Text] [Related]
13. High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial.
Mugwanya K; Baeten JM; Mugo NR; Irungu E; Ngure K; Celum C
J Infect Dis; 2011 Dec; 204(12):1912-7. PubMed ID: 21998479
[TBL] [Abstract][Full Text] [Related]
14. Absence of transmission from HIV-infected individuals with HAART to their heterosexual serodiscordant partners.
Del Romero J; Río I; Castilla J; Baza B; Paredes V; Vera M; Rodríguez C
Enferm Infecc Microbiol Clin; 2015 Dec; 33(10):666-72. PubMed ID: 25555636
[TBL] [Abstract][Full Text] [Related]
15. Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2.
Roxby AC; Drake AL; Ongecha-Owuor F; Kiarie JN; Richardson B; Matemo DN; Overbaugh J; Emery S; John-Stewart GC; Wald A; Farquhar C
PLoS One; 2012; 7(6):e38622. PubMed ID: 22701683
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors for HSV-2 Infection among Sexual Partners of HSV-2/HIV-1 Co-Infected Persons.
Mujugira A; Magaret AS; Baeten JM; Celum C; Lingappa J
BMC Res Notes; 2011 Mar; 4():64. PubMed ID: 21406077
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for incident HSV-2 infections among a prospective cohort of HIV-1-discordant couples in China.
Ding Y; Wu Z; Duan S; Rou K; Yang Y; Wang J; Gao M; Ye R; Detels R; He N
Sex Transm Infect; 2016 Feb; 92(1):76-82. PubMed ID: 26139205
[TBL] [Abstract][Full Text] [Related]
18. High-dose valacyclovir decreases plasma HIV-1 RNA more than standard-dose acyclovir in persons coinfected with HIV-1 and HSV-2: a randomized crossover trial.
Perti T; Saracino M; Baeten JM; Johnston C; Diem K; Ocbamichael N; Huang ML; Selke S; Magaret A; Corey L; Wald A
J Acquir Immune Defic Syndr; 2013 Jun; 63(2):201-8. PubMed ID: 23542637
[TBL] [Abstract][Full Text] [Related]
19. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.
Celum C; Wald A; Hughes J; Sanchez J; Reid S; Delany-Moretlwe S; Cowan F; Casapia M; Ortiz A; Fuchs J; Buchbinder S; Koblin B; Zwerski S; Rose S; Wang J; Corey L;
Lancet; 2008 Jun; 371(9630):2109-19. PubMed ID: 18572080
[TBL] [Abstract][Full Text] [Related]
20. The effect of valacyclovir on HIV and HSV-2 in HIV-infected persons on antiretroviral therapy with previously unrecognised HSV-2.
Van Wagoner N; Geisler WM; Bachmann LH; Hook EW
Int J STD AIDS; 2015 Jul; 26(8):574-81. PubMed ID: 25147236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
